CARDINAL HEALTH INC

10-K & 10-Q Filings

Cardinal Health is a global healthcare services and products company based in the United States. The company was formed in 1979 and provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. Cardinal Health's business strategy includes distributing pharmaceuticals and medical products, cost-effective solutions that enhance supply chain efficiency, and connecting patients, providers, payers, pharmacists, and manufacturers for integrated care coordination and better patient management. The company operates in two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare and consumer products in the United States. It also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products, operates nuclear pharmacies and radiopharmaceutical manufacturing facilities, and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products in the United States, Canada, Europe, Asia, and other markets. It also distributes a broad range of medical, surgical, and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers in the United States and Canada. The Medical segment also distributes medical products to patients' homes in the United States through its Cardinal Health at-Home Solutions division. Cardinal Health's website is www.cardinalhealth.com, and its ticker symbol is CAH. The company's fiscal year ends on June 30. In fiscal 2023, the company reported revenue of $205.0 billion, a 13% increase from the prior year, driven primarily by Pharmaceutical segment sales growth. The company's cash and equivalents balance was $4.0 billion at June 30, 2023.

12 mos ending Jun 30, 201212 mos ending Jun 30, 201312 mos ending Jun 30, 201412 mos ending Jun 30, 201512 mos ending Jun 30, 201612 mos ending Jun 30, 201712 mos ending Jun 30, 201812 mos ending Jun 30, 201912 mos ending Jun 30, 202012 mos ending Jun 30, 202112 mos ending Jun 30, 202212 mos ending Jun 30, 20239 mos ending Mar 31, 20239 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$107552.00
101093.00
91084.00
102531.00
121546.00
129976.00
136809.00
145534.00
152922.00
162467.00
181364.00
205012.00
151559.00
167119.00
6.04%10.27%Cost of Revenue (-)
$103011.00
96172.00
85923.00
96819.00
115003.00
123432.00
129628.00
138700.00
146054.00
155689.00
174819.00
198123.00
146497.00
161558.00
6.13%10.28%Gross Profit (+)
$4541.00
4921.00
5161.00
5712.00
6543.00
6544.00
7181.00
6834.00
6868.00
6778.00
6545.00
6889.00
5062.00
5561.00
3.86%9.86%Selling, General & Administrative (-)
$2677.00
2875.00
3028.00
3240.00
3648.00
3775.00
4596.00
4480.00
4572.00
4533.00
4557.00
4834.00
3567.00
3762.00
5.52%5.47%Non-recurring Operating Expenses (-)
$18.00
33.00
10.00
49.00
-44.00
104.00
335.00
161.00
5863.00
1243.00
210.00
-207.00
-194.00
135.00
169.59%Operating Expenses (-)
$2749.00
3925.00
3276.00
3551.00
4084.00
4424.00
7055.00
4774.00
10966.00
6306.00
7141.00
6162.00
4472.00
4726.00
7.61%5.68%Costs & Expenses (Total) (-)
$105760.00
100097.00
89199.00
100370.00
119087.00
127856.00
136683.00
143474.00
157020.00
161995.00
181960.00
204285.00
150969.00
166339.00
6.17%10.18%Operating Income/Loss (+)
$1792.00
996.00
1885.00
2161.00
2459.00
2120.00
126.00
2060.00
-4098.00
472.00
-596.00
727.00
590.00
835.00
-7.87%41.53%Non-operating Income/Expense (+)
$1.00
15.00
46.00
-53.00
-5.00
5.00
-25.00
-15.00
-15.00
33.00
-26.00
4.00
5.00
25.00
13.43%400.00%Interest Expense (-)
$95.00
123.00
133.00
141.00
178.00
201.00
329.00
294.00
238.00
180.00
149.00
93.00
78.00
55.00
-0.19%-29.49%Earnings before Tax (+)
$1698.00
888.00
1798.00
1967.00
2276.00
1924.00
-228.00
1751.00
-3772.00
323.00
-769.00
638.00
517.00
805.00
-8.51%55.71%Tax Expense (-)
$628.00
553.00
635.00
755.00
845.00
630.00
-487.00
386.00
-79.00
-289.00
163.00
376.00
189.00
186.00
-4.56%-1.59%Income/Loss (Continuing Operations) (+)
$1070.00
335.00
1163.00
1212.00
1431.00
1294.00
259.00
1365.00
-3693.00
612.00
-932.00
262.00
328.00
619.00
-12.01%88.72%Income/Loss (Discontinued Operations) (+)
$-1.00
-1.00
3.00
3.00
Profit/Loss (+)
$
1431.00
1294.00
259.00
1365.00
-3693.00
612.00
-932.00
262.00
328.00
619.00
88.72%Net Income/Loss (NCI) (-)
$
4.00
6.00
3.00
2.00
3.00
1.00
1.00
1.00
3.00
3.00
0.00%Net Income/Loss (+)
$1069.00
334.00
1166.00
1215.00
1427.00
1288.00
256.00
1363.00
-3696.00
611.00
-933.00
261.00
325.00
616.00
-12.03%89.54%Net Income/Loss (Common) (+)
$1069.00
334.00
1166.00
1215.00
1427.00
1288.00
256.00
1363.00
-3696.00
611.00
-933.00
261.00
325.00
616.00
-12.03%89.54%EPS (Basic)
$3.10
0.98
3.42
3.66
4.36
4.06
0.82
4.55
-12.61
2.09
-3.35
1.00
1.24
2.51
-9.77%102.42%EPS (Diluted)
$3.06
0.97
3.38
3.62
4.32
4.03
0.81
4.53
-12.61
2.08
-3.35
1.00
1.23
2.49
-9.67%102.44%Weighted Avg Shares (Basic)
345.00
341.00
341.00
332.00
327.00
317.00
313.00
300.00
293.00
292.00
279.00
261.00
263.00
245.00
-2.50%-6.84%Weighted Avg Shares (Diluted)
349.00
344.00
345.00
335.00
330.00
320.00
315.00
301.00
293.00
294.00
279.00
262.00
264.00
247.00
-2.57%-6.44%Cash
$2274.00
1901.00
2865.00
4616.00
2356.00
6879.00
1763.00
2531.00
2771.00
3407.00
4717.00
4043.00
3990.00
3718.00
5.37%-6.82%Receivables
$6355.00
6304.00
5380.00
6523.00
7405.00
8048.00
7800.00
8448.00
8264.00
9103.00
10561.00
11344.00
10992.00
11566.00
5.41%5.22%Inventory
$7864.00
8373.00
8266.00
9211.00
10615.00
11301.00
12308.00
12822.00
13198.00
14594.00
15636.00
15940.00
16620.00
17277.00
6.63%3.95%Other Assets (Current)
$1017.00
1192.00
1428.00
1402.00
1580.00
2117.00
2682.00
1946.00
1707.00
3944.00
2021.00
2362.00
1895.00
3161.00
7.96%66.81%Assets (Current)
$17510.00
17770.00
17939.00
21752.00
21956.00
28345.00
24553.00
25747.00
25940.00
31048.00
32935.00
33833.00
33497.00
35734.00
6.17%6.68%Property, Plant & Equipment (Net)
$1551.00
1489.00
1459.00
1506.00
1796.00
1879.00
2487.00
2356.00
2366.00
2360.00
2361.00
2462.00
2362.00
2470.00
4.29%4.57%Other Assets
$5199.00
6560.00
6635.00
6884.00
10370.00
9888.00
12911.00
12860.00
12460.00
11045.00
8582.00
7266.00
7518.00
7688.00
3.09%2.26%Assets (Non-current)
$6750.00
8049.00
8094.00
8390.00
12166.00
11767.00
15398.00
15216.00
14826.00
13405.00
10943.00
9728.00
9880.00
10158.00
3.38%2.81%Assets (Total)
$24260.00
25819.00
26033.00
30142.00
34122.00
40112.00
39951.00
40963.00
40766.00
44453.00
43878.00
43417.00
43377.00
45880.00
5.43%5.77%Accounts Payable
$11726.00
12295.00
12149.00
14368.00
17306.00
17906.00
19677.00
21535.00
21374.00
23700.00
27128.00
29813.00
29601.00
32089.00
8.85%8.41%Debt (Current)
$476.00
168.00
801.00
281.00
587.00
1327.00
1001.00
452.00
10.00
871.00
580.00
792.00
26.00
1187.00
4.74%4465.38%Other Liabilities (Current)
$1972.00
2127.00
2165.00
2594.00
1808.00
1988.00
2002.00
2122.00
2231.00
2957.00
2842.00
3059.00
2876.00
3030.00
4.07%5.35%Liabilities (Current)
$14174.00
14590.00
15115.00
17243.00
19701.00
21221.00
22893.00
24109.00
23615.00
27624.00
30550.00
33706.00
32503.00
36306.00
8.19%11.70%Debt (Non-current)
$2418.00
3686.00
3171.00
5211.00
4952.00
9068.00
8012.00
7579.00
6765.00
5365.00
4735.00
3909.00
4708.00
4667.00
4.46%-0.87%Other Liabilities
$1424.00
1568.00
1346.00
1432.00
2898.00
2995.00
2987.00
2945.00
8594.00
9670.00
9299.00
8653.00
8384.00
8169.00
17.83%-2.56%Liabilities (Non-current)
$3842.00
5254.00
4517.00
6643.00
7850.00
12063.00
10999.00
10524.00
15359.00
15035.00
14034.00
12562.00
13092.00
12836.00
11.37%-1.96%Liabilities (Total)
$18016.00
19844.00
19632.00
23886.00
27551.00
33284.00
33892.00
34633.00
38974.00
42659.00
44584.00
46268.00
45595.00
49142.00
8.95%7.78%Treasury Stock
$816.00
1084.00
1423.00
2245.00
2759.00
731.00
1224.00
1790.00
2066.00
2186.00
3128.00
4914.00
4554.00
5703.00
17.73%25.23%Retained Earnings
$4093.00
4038.00
4774.00
5521.00
6419.00
4967.00
4645.00
5434.00
1170.00
1205.00
-280.00
-534.00
-342.00
-289.00
15.50%AOCI
$37.00
68.00
70.00
-23.00
-116.00
-125.00
-92.00
-79.00
-104.00
-34.00
-114.00
-151.00
-142.00
-160.00
-12.68%Shareholder's Equity
$6244.00
5975.00
6401.00
6256.00
6571.00
6828.00
6059.00
6330.00
1792.00
1794.00
-706.00
-2851.00
-2218.00
-3262.00
-47.07%Liabilities & Equity
$24260.00
25819.00
26033.00
30142.00
34122.00
40112.00
39951.00
40963.00
40766.00
44453.00
43878.00
43417.00
43377.00
45880.00
5.43%5.77%Net Income/Loss
$1069.00
334.00
1166.00
1215.00
1431.00
1294.00
259.00
1365.00
-3693.00
612.00
-932.00
262.00
328.00
619.00
-12.00%88.72%Depreciation & Amortization
$325.00
397.00
459.00
451.00
641.00
717.00
1032.00
1000.00
913.00
783.00
692.00
692.00
516.00
524.00
7.11%1.55%Increase/Decrease in Working Capital
$434.00
9.00
-755.00
-452.00
-623.00
1294.00
-870.00
-755.00
-6061.00
-289.00
-1124.00
-464.00
-106.00
227.00
314.15%Share-based Compensation
$85.00
93.00
96.00
110.00
111.00
96.00
85.00
82.00
90.00
89.00
81.00
96.00
69.00
88.00
1.11%27.54%Adjustments to Reconcile Net Income
$106.00
1392.00
1361.00
1328.00
1540.00
-110.00
2509.00
1357.00
5653.00
1817.00
4054.00
2577.00
1653.00
1066.00
33.65%-35.51%Net Cash (Operating)
$1176.00
1727.00
2524.00
2540.00
2971.00
1184.00
2768.00
2722.00
1960.00
2429.00
3122.00
2839.00
1981.00
1685.00
8.34%-14.94%Capital Expenditure
$437.00
2434.00
768.00
803.00
4089.00
531.00
6632.00
410.00
375.00
403.00
-545.00
479.00
272.00
1491.00
0.84%448.16%Net Cash (Investing)
$-377.00
-2375.00
-850.00
-849.00
-4080.00
-405.00
-5608.00
338.00
493.00
-378.00
567.00
-454.00
-248.00
-2015.00
-712.50%Increase/Decrease in Debt
$258.00
-306.00
112.00
-1233.00
20.00
-307.00
-1004.00
-1102.00
-1401.00
-570.00
-885.00
-579.00
-571.00
1116.00
295.45%Increase/Decrease in Equity
$-450.00
-450.00
-673.00
-1036.00
-651.00
-600.00
-550.00
-600.00
-350.00
-200.00
-1000.00
-2000.00
-1500.00
-750.00
50.00%Interest Expenses
$118.00
128.00
152.00
150.00
174.00
200.00
320.00
285.00
226.00
182.00
153.00
203.00
5.06%Dividends Paid
$300.00
353.00
415.00
460.00
512.00
577.00
581.00
577.00
569.00
573.00
559.00
525.00
399.00
377.00
5.22%-5.51%Net Cash (Financing)
$-454.00
275.00
-710.00
60.00
-1139.00
3746.00
-2276.00
-2293.00
-2200.00
-1317.00
-2463.00
-3051.00
-2459.00
12.00
100.49%Cash Taxes Paid
$513.00
899.00
632.00
529.00
635.00
686.00
425.00
311.00
368.00
273.00
-766.00
156.00
-10.26%Effect of Exchange Rate
$
-12.00
-2.00
4.00
1.00
-13.00
11.00
-25.00
-8.00
-1.00
-7.00
-600.00%Increase/Decrease in Cash
$345.00
-373.00
964.00
1751.00
-2260.00
4523.00
-5116.00
768.00
240.00
636.00
1310.00
-674.00
-727.00
-325.00
55.30%Cash (Beginning)
$1929.00
2274.00
1901.00
2865.00
4616.00
2356.00
6879.00
1763.00
2531.00
2771.00
3407.00
4717.00
4717.00
4043.00
8.47%-14.29%Cash (Ending)
$2274.00
1901.00
2865.00
4616.00
2356.00
6879.00
1763.00
2531.00
2771.00
3407.00
4717.00
4043.00
3990.00
3718.00
5.37%-6.82%NOPAT
$1250.60
-12.34
1222.42
1579.83
1772.94
1364.12
395.13
1694.12
-4183.83
894.32
-469.67
549.24
374.31
642.07
-7.21%71.53%Gross Margin %
4.22%
4.87%
5.67%
5.57%
5.38%
5.03%
5.25%
4.70%
4.49%
4.17%
3.61%
3.36%
3.34%
3.33%
Operating Margin %
1.67%
0.99%
2.07%
2.11%
2.02%
1.63%
0.09%
1.42%
-2.68%
0.29%
-0.33%
0.35%
0.39%
0.50%
NOPAT Margin %
1.16%
-0.01%
1.34%
1.54%
1.46%
1.05%
0.29%
1.16%
-2.74%
0.55%
-0.26%
0.27%
0.25%
0.38%
Net Margin %
0.99%
0.33%
1.28%
1.19%
1.17%
0.99%
0.19%
0.94%
-2.42%
0.38%
-0.51%
0.13%
0.21%
0.37%
Tax Rate %
30.21%
101.24%
35.15%
26.89%
27.90%
35.65%
-213.60%
17.76%
-2.09%
-89.47%
21.20%
24.45%
36.56%
23.11%
ROA
5.15%
-0.05%
4.70%
5.24%
5.20%
3.40%
0.99%
4.14%
-10.26%
2.01%
-1.07%
1.27%
0.86%
1.40%
ROE
20.03%
-0.21%
19.10%
25.25%
26.98%
19.98%
6.52%
26.76%
-233.47%
49.85%
66.53%
-19.26%
-16.88%
-19.68%
ROIC
23.45%
-0.26%
25.80%
25.52%
44.75%
14.82%
10.74%
47.57%
-101.81%
20.87%
-9.94%
22.45%
12.80%
44.99%
Asset Turnover
4.43
3.92
3.50
3.40
3.56
3.24
3.42
3.55
3.75
3.65
4.13
4.72
3.49
3.64
Inventory Turnover
13.10
11.49
10.39
10.51
10.83
10.92
10.53
10.82
11.07
10.67
11.18
12.43
8.81
9.35
Equity Multiplier
3.89
4.32
4.07
4.82
5.19
5.87
6.59
6.47
22.75
24.78
-62.15
-15.23
-19.56
-14.06
Current Ratio
1.24
1.22
1.19
1.26
1.11
1.34
1.08
1.07
1.10
1.13
1.08
1.00
1.03
0.98
Quick Ratio
0.61
0.56
0.55
0.65
0.50
0.70
0.42
0.46
0.47
0.45
0.50
0.46
0.46
0.42
Debt/Equity Ratio
0.46
0.65
0.62
0.88
0.84
1.52
1.49
1.27
3.78
3.48
-7.53
-1.65
-2.13
-1.79
Interest Coverage Ratio
15.19
7.78
12.40
14.41
14.13
10.60
0.39
7.23
-18.13
2.59
-3.90
3.58
Working Capital/Sales
0.04
0.03
0.04
0.05
0.02
0.06
0.01
0.01
0.01
0.01
0.01
-0.00
0.00
-0.01
Dividend Payout Ratio %
23.99%
2861.12%
33.95%
29.12%
28.88%
42.30%
147.04%
34.06%
13.60%
64.07%
119.02%
95.59%
106.60%
58.72%
Total Payout
$610.00
1237.00
1128.00
2879.00
1317.00
1684.00
2455.00
2564.00
2546.00
1525.00
2597.00
3307.00
2470.00
11.00
16.61%-99.55%Payout Ratio %
48.78%
10026.07%
92.28%
182.24%
74.28%
123.45%
621.31%
151.35%
60.85%
170.52%
552.94%
602.11%
659.87%
1.71%